Clinical Trial Details
GSK Summit COPD Research Study Official Title:
GSK Summit COPD Research Study
Start Date September 25, 2013
End Date March 25, 2014
| Gender Preference |
|None|| Age Group |
|40 - 80 years|
| Principal Investigator |
|Dr. Alejandro Comellas|
| Contact Info |
Kim Sprenger, RN BSN
|Department or Field of Study|
We are pleased to inform you that our medical center is participating in a clinical research study for individuals with chronic obstructive pulmonary disease (COPD). The purpose of the study is to evaluate the long term benefit of an investigational drug for COPD. We are notifying you and others that have COPD of the opportunity to participate in this study.
You may qualify to participate in this study if you are between the ages of 40 and 80 and have moderate COPD. You must also have a history of smoking and a history or be at risk of heart disease. We have enclosed some brief information for you to consider.
If you are interested in learning more about the study or have any questions, please contact us. Contacting us does not mean you are obligated to participate or that you will be eligible to participate. Eligibility will depend on a range of criteria.
Thank you for your consideration, we look forward to hearing from you!
|copd, cardiovascular disease, lung, breathing ; |